RAVICTI 1.1 GM in 1 mL Oral Solution

RxCUI
1368459
RxNorm name
RAVICTI 1.1 GM in 1 mL Oral Solution
Display name
RAVICTI 1.1 GM in 1 mL Oral Solution
Full name
RAVICTI 1.1 GM in 1 mL Oral Solution
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:08

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
RavictiGLYCEROL PHENYLBUTYRATEHorizon Therapeutics USA, Inc.900e7dc0-9afe-4f50-80de-90567bb785192025-10-29Warnings, Adverse reactionsExact identifier
rxcui: 1368459

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
900e7dc0-9afe-4f50-80de-90567bb78519RAVICTI 1.1 GM in 1 mL Oral SolutionPSN13These highlights do not include all the information needed to use RAVICTI safely and effectively. See full prescribing information for RAVICTI. RAVICTI ® (glycerol phenylbutyrate) oral liquid Initial U.S. Approval: 199620251029
900e7dc0-9afe-4f50-80de-90567bb78519Ravicti 1100 MG/ML Oral SolutionSY13These highlights do not include all the information needed to use RAVICTI safely and effectively. See full prescribing information for RAVICTI. RAVICTI ® (glycerol phenylbutyrate) oral liquid Initial U.S. Approval: 199620251029
900e7dc0-9afe-4f50-80de-90567bb78519glycerol phenylbutyrate 1100 MG/ML Oral Solution [Ravicti]SBD13These highlights do not include all the information needed to use RAVICTI safely and effectively. See full prescribing information for RAVICTI. RAVICTI ® (glycerol phenylbutyrate) oral liquid Initial U.S. Approval: 199620251029